使用深度学习预测存活与死亡患者的重症监护住院时长
研究利用电子ICU研究机构数据库2017至2019年194家美国医院329个ICU的669,876例ICU入住(628,815例患者),开发CCOPM深度学习竞争风险模型,用入住ICU后首个24小时的 patient characteristics、生命体征和实验室检查预测ICU及住院时长。数据按2:1:1随机分为训练集、验证集和测试集。测试集中,ICU时长模型在存活与死亡人群的个体水平R2分别为0.29和0.23,ICU水平分别为0.48和0.23;住院时长模型个体水平R2分别为0.46和0.52,ICU水平分别为0.71和0.64。在含APACHE IVb预测的子集中,CCOPM的ICU时长R2为0.30和0.23,APACHE IVb为0.16和零;住院时长CCOPM为0.39和0.40,APACHE IVb为0.27和零。
要点
- CCOPM用入住ICU后首个24小时的患者特征、生命体征和实验室检查预测ICU及住院时长,采用竞争风险深度学习框架分别建模存活与死亡患者。
- 测试集中ICU时长模型个体水平R2在存活人群为0.29、死亡人群为0.23,ICU水平分别为0.48和0.23。
- 测试集中住院时长模型个体水平R2在存活人群为0.46、死亡人群为0.52,ICU水平分别为0.71和0.64。
- 在含APACHE IVb预测的子集中,ICU时长R2存活人群CCOPM 0.30 vs APACHE IVb 0.16,死亡人群CCOPM 0.23 vs APACHE IVb 零。
- 住院时长R2在存活人群CCOPM 0.39 vs APACHE IVb 0.27,死亡人群CCOPM 0.40 vs APACHE IVb 零。
适用人群与场景
- 2017至2019年美国194家医院329个ICU的669,876例ICU入住,涉及628,815例患者,数据来自电子ICU研究机构数据库中参与远程重症监护项目的ICU。
研究设计与关键结果
- 研究设计为预测模型开发,使用深度学习框架建模竞争风险下的时间至事件,数据按2:1:1随机分为训练集、验证集和测试集。
- 模型性能用决定系数(R2)、一致性指数、平均绝对误差和校准评估。
- 测试集个体水平ICU时长模型R2在存活人群为0.29、死亡人群为0.23;ICU水平R2分别为0.48和0.23。
- 测试集个体水平住院时长模型R2在存活人群为0.46、死亡人群为0.52;ICU水平R2分别为0.71和0.64。
- 在含APACHE IVb预测的测试集子集中,ICU时长R2在存活人群CCOPM为0.30、APACHE IVb为0.16,死亡人群CCOPM为0.23、APACHE IVb为零。
- 同一子集中住院时长R2在存活人群CCOPM为0.39、APACHE IVb为0.27,死亡人群CCOPM为0.40、APACHE IVb为零。
证据类型、等级与局限
- 证据类型:基于电子健康记录的预测模型开发研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这一新时长模型在实现跨不同风险谱ICU的更公平基准比较方面迈出了一步。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Length of stay (LOS) models support evaluating ICU care; however, current benchmarking models fail to consider differences in LOS between surviving and nonsurviving patients, which can lead to biased predictions toward the surviving population. We aim to develop a model addressing this as well as documentation bias to improve ICU benchmarking.
DESIGN: The Critical Care Outcomes Prediction Model (CCOPM) LOS uses patient characteristics, vitals, and laboratories during the first 24 hours of ICU admission to predict LOS in the hospital and ICU using a deep learning framework for modeling time to events with competing risk. Data was randomly divided into training, validation, and test (hold out) sets in a 2:1:1 ratio.
SETTING: Electronic ICU Research Institute database from participating tele-critical care programs.
PATIENTS: Six hundred sixty-nine thousand eight hundred seventy-six ICU admissions pertaining to 628,815 patients from 329 ICUs in 194 U.S. hospitals, from 2017 to 2019.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Model performance was assessed using the coefficient of determination ( R2 ), concordance index, mean absolute error, and calibration. For individual stays in the test set, the ICU LOS model presented R2 = 0.29 and 0.23 for surviving and nonsurviving populations, respectively, at the individual level and R2 = 0.48 and 0.23 at the ICU level. Conversely, hospital LOS model presented R2 = 0.46 and 0.52 at the individual level and R2 = 0.71 and 0.64 at the ICU level. In the subset of the test set containing predictions from Acute Physiology and Chronic Health Evaluation (APACHE) IVb, R2 of ICU LOS for surviving and nonsurviving populations was, respectively, 0.30 and 0.23 for the CCOPM and 0.16 and zero for APACHE IVb. For hospital LOS, the values were R2 = 0.39 and 0.40 for the CCOPM and 0.27 and zero for APACHE IVb.
CONCLUSIONS: This novel LOS model represents a step forward in achieving more equitable benchmarking across diverse ICU settings with varying risk profiles.
参考来源
- Brochini L, Liu X, Atallah L, et al. Prediction of Intensive Care Length of Stay for Surviving and Nonsurviving Patients Using Deep Learning. Crit Care Med. 2025. PMID: 39928543. doi:10.1097/CCM.0000000000006588
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。